Yugal Implants Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 23-10-2024
- Paid Up Capital ₹ 0.10 M
as on 23-10-2024
- Company Age 9 Year, 5 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 44.14 Cr
as on 23-10-2024
- Revenue 4.92%
(FY 2023)
- Profit 22.03%
(FY 2023)
- Ebitda 4.61%
(FY 2023)
- Net Worth 17.39%
(FY 2023)
- Total Assets 134.68%
(FY 2023)
About Yugal Implants
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹44.14 Cr.
Alok Sharma and Anita Jain serve as directors at the Company.
- CIN/LLPIN
U01403DL2015PTC288563
- Company No.
288563
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Dec 2015
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Yugal Implants?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alok Sharma  | Director | 16-Dec-2015 | Current |
| Anita Jain | Director | 25-Feb-2019 | Current |
Financial Performance and Corporate Structure Insights of Yugal Implants.
Yugal Implants Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.92% increase. The company also saw a substantial improvement in profitability, with a 22.03% increase in profit. The company's net worth Soared by an impressive increase of 17.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Yugal Implants?
In 2023, Yugal Implants had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Bhumesh Agronomy Private LimitedActive 9 years 2 months
Alok Sharma and Anita Jain are mutual person
- Ramsetu Cultivation Private LimitedActive 9 years 1 month
Alok Sharma and Anita Jain are mutual person
- Anushthan Nutrients Private LimitedActive 9 years 1 month
Alok Sharma and Anita Jain are mutual person
- Amishi Agri Products Private LimitedActive 9 years 4 months
Alok Sharma and Anita Jain are mutual person
- Deen Dayal Organic Farms Private LimitedActive 9 years 3 months
Alok Sharma and Anita Jain are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Aug 2024 | ₹4.50 Cr | Open |
Others Creation Date: 18 Jul 2024 | ₹3.65 Cr | Open |
Others Creation Date: 21 May 2024 | ₹3.60 Cr | Open |
How Many Employees Work at Yugal Implants?
Unlock and access historical data on people associated with Yugal Implants, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Yugal Implants, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yugal Implants's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
